NASDAQ$MEDP
Medpace Holdings Inc. · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
Medpace Holdings, Inc. reported a strong Q4 2024 with revenue growth of 7.7% YoY to $536.6 million. Net income increased significantly to $117.0 million, with diluted EPS of $3.67. The company's backlog increased slightly, while net new business awards saw a decline of 13.8%. EBITDA rose by 39.3% to $133.5 million, with an EBITDA margin of 24.9%.
Headline financials
Revenue & EPS history
Medpace · Revenue · Quarterly
$537M
Forward guidance
Medpace projects 2025 revenue in the range of $2.11 billion to $2.21 billion, representing growth of up to 4.8%. GAAP net income is expected to be between $378.0 million and $402.0 million, with diluted EPS in the range of $11.93 to $12.69.
Tailwinds
- Revenue expected to grow up to 4.8% in 2025
- Net income projected to remain strong at up to $402.0 million
- EBITDA forecasted to be between $462.0 million and $492.0 million
- Strong balance sheet with cash and cash equivalents of $669.4 million
- Stock repurchase program increased by $600 million
Headwinds
- Net new business awards declined 13.8% YoY in Q4 2024
- Backlog conversion rate of 18.3%, indicating slower contract realization
- Projected revenue growth of up to 4.8% lower than previous year’s 11.8%
- Potential impact from economic uncertainties and market conditions
- Guidance does not account for possible share repurchases affecting EPS
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
-1.7%
Avg return
Earnings day
-1.6%
Avg return
5 days after
+1.1%
Avg return
30 days after
44%
19 / 43 earnings
Positive
+39.0%
Q3 2022
Best reaction
-31.5%
Q1 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.5% | -19.4% | -14.9% | |
| Q4 2025 | -15.9% | -19.3% | -16.3% | |
| Q3 2025 | +9.0% | +6.2% | +8.2% | |
| Q2 2025 | -0.2% | +1.5% | +7.0% | |
| Q1 2025 | -2.3% | +3.3% | +1.4% | |
| Q4 2024 | -7.5% | -4.0% | -10.3% | |
| Q3 2024 | -8.4% | -7.3% | -8.5% | |
| Q2 2024 | -15.2% | -9.5% | -6.1% | |
| Q1 2024 | +9.4% | +6.4% | +4.8% | |
| Q4 2023 | +11.6% | +20.0% | +25.0% | |
| Q3 2023 | +18.8% | +9.2% | +20.8% | |
| Q2 2023 | +4.6% | +3.9% | +1.8% | |
| Q1 2023 | +10.2% | +5.9% | +7.2% | |
| Q4 2022 | -2.9% | -7.6% | -20.4% | |
| Q3 2022 | +39.0% | +41.5% | +39.2% | |
| Q2 2022 | -2.9% | +5.0% | +3.8% | |
| Q1 2022 | -12.0% | -11.3% | -12.2% | |
| Q4 2021 | -20.6% | -18.2% | -12.1% | |
| Q3 2021 | +13.9% | +21.1% | +14.4% | |
| Q2 2021 | -6.0% | -3.4% | -0.8% | |
| Q1 2021 | -12.8% | -11.3% | -13.3% | |
| Q4 2020 | -2.7% | -5.3% | -2.0% | |
| Q3 2020 | -6.1% | -4.8% | +4.4% | |
| Q2 2020 | +15.5% | +12.8% | +16.7% | |
| Q1 2020 | -2.5% | -11.9% | +9.0% | |
| Q4 2019 | +2.4% | -9.7% | -31.7% | |
| Q3 2019 | +0.8% | -0.5% | +3.8% | |
| Q2 2019 | +24.9% | +19.9% | +27.2% | |
| Q1 2019 | -4.3% | -1.6% | -4.7% | |
| Q4 2018 | -21.3% | -21.8% | -18.4% | |
| Q3 2018 | +0.2% | +13.9% | +21.8% | |
| Q2 2018 | +28.6% | +24.4% | +23.4% | |
| Q1 2018 | +2.3% | -0.0% | +12.9% | |
| Q4 2017 | -15.7% | -14.3% | -5.3% | |
| Q3 2017 | +6.2% | +5.6% | -3.7% | |
| Q2 2017 | +8.0% | +15.1% | +17.2% | |
| Q1 2016 | -31.5% | -29.1% | -12.6% | |
| Q1 2017 | -29.1% | -27.5% | -12.3% | |
| Q4 2014 | -21.3% | -20.7% | -22.2% | |
| Q2 2016 | -21.3% | -20.7% | -22.2% | |
| Q4 2016 | -19.8% | -20.1% | -22.3% | |
| Q3 2016 | +3.8% | +8.1% | +24.0% | |
| Q4 2015 | +3.8% | +8.1% | +24.0% | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q1 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro